Heart Septal Defects: Clinical Trials

13 trials for Heart Septal Defects, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 unknown, 1 active not recruiting, 1 terminated. 13 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 6, Unknown 4, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 12Completed 1, Unknown 1
Phase 32Unknown 2

Follow Heart Septal Defects: new trials by email Literature Review of Heart Septal Defects trials Research Report on Heart Septal Defects

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
Aspirin 300mg, Metoprolol 25mg, Clopidogrel 75mg - Patent Foramen Ovale, Migraine
Phase 2CompletedChinese Academy of Medical Sciences, Fuwai Hospital10002022-10-152026-04-22
Optical Tissue Identification for Myocardial Architecture
Fluorescite, Cellvizio 100 Series System with Confocal Miniprobes - Ventricular Septal Defect, Complete Atrioventricular Canal
Phase 2Active not recruitingAditya Kaza702019-12-202023-06-15
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
MPC; rexlemestrocel-L - Hypoplastic Left Heart Syndrome, Atrioventricular Canal
Phase 1 / Phase 2UnknownBoston Children's Hospital192017-11-272023-04-21
Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches
the transcatheter closure of PFO - Patent Foramen Ovale
Phase 2UnknownFirst Affiliated Hospital Xi'an Jiaotong University1002017-01-012017-07-19
Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli
Apixaban, Placebo - Patent Foramen Ovale, Cardiac Implantable Electronic Device
Phase 2WithdrawnMayo Clinic2015-05-012018-11-16
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Intravenous L-Citrulline, Placebo of Intravenous L-Citrulline - Atrial Septal Defect, Ventricular Septal Defect
Phase 1 / Phase 2CompletedAsklepion Pharmaceuticals, LLC222010-09-012022-07-27
Measures to Lower the Stress Response in Pediatric Cardiac Surgery
Fentanyl (High Dose), Fentanyl (Low Dose), Fentanyl (Low Dose) + Dexmedetomidine - Tetralogy of Fallot (TOF), Ventricular Septal Defects (VSD)
Phase 2CompletedNationwide Children's Hospital522008-11-012018-07-27
Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt
Polidocanol (1%) Microfoam (Varisolve), Endovenous Microfoam Occlusion - Varicose Veins
Phase 2CompletedBoston Scientific Corporation602007-03-012021-04-21
PRIMA PFO Migraine Trial
AMPLATZER® PFO Occluder Device - Migraine, Migraine With Aura
Phase 2TerminatedAbbott Medical Devices1072006-05-012019-02-04
MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant
BioSTAR Septal Repair Implant System, Sham Procedure - Migraine, Aura
Phase 2 / Phase 3UnknownNMT Medical6102006-02-012008-01-25
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
saline, ketamine - Ventricular Septal Defect
Phase 2CompletedArkansas Children's Hospital Research Institute242004-07-012007-11-12
Hypertonic Saline Dextran in Pediatric Cardiac Surgery
7.5% NaCl in 6% dextran 70 solution - Heart Defects, Congenital, Transposition of Great Vessels
Phase 2CompletedOslo University Hospital142003-06-012011-07-01
Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)
STARFlex septal closure system, Best medical therapy - Patent Foramen Ovale, Stroke
Phase 2 / Phase 3UnknownNMT Medical9002003-06-012008-12-30

Narrower conditions

Foramen Ovale, Patent (7)  ·  Heart Septal Defects, Ventricular (5)  ·  Migraine Disorders (4)  ·  Endocardial Cushion Defects (3)  ·  Heart Septal Defects, Atrial (3)  ·  Atrioventricular Septal Defect (2)  ·  Stroke (2)  ·  Cognitive Dysfunction (1)  ·  Complete atrioventricular septal defect (1)  ·  Embolism, Paradoxical (1)  ·  Epilepsy (1)  ·  Fractures, Stress (1)  ·  Headache (1)  ·  Heart Defects, Congenital (1)  ·  Hypoplastic Left Heart Syndrome (1)

Broader conditions

Cardiovascular Abnormalities (13)  ·  Cardiovascular Diseases (13)  ·  Congenital Abnormalities (13)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (13)  ·  Heart Diseases (13)  ·  Heart Defects, Congenital (12)  ·  Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Nervous System Diseases (6)  ·  Heart Septal Defects, Atrial (5)  ·  Headache Disorders (4)  ·  Headache Disorders, Primary (4)  ·  Vascular Diseases (3)  ·  Cerebrovascular Disorders (2)

Interventions

Aspirin (1)  ·  Clopidogrel (1)  ·  Dexmedetomidine (1)  ·  Fentanyl (1)  ·  Fluorescein (1)  ·  Ketamine (1)  ·  Metoprolol (1)  ·  Polidocanol (1)  ·  Rivaroxaban (1)  ·  Sodium Chloride (1)  ·  apixaban (1)

Sponsors

NMT Medical (2)  ·  Abbott Medical Devices (1)  ·  Aditya Kaza (1)  ·  Arkansas Children's Hospital Research Institute (1)  ·  Asklepion Pharmaceuticals, LLC (1)  ·  Boston Children's Hospital (1)  ·  Boston Scientific Corporation (1)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Mayo Clinic (1)  ·  Nationwide Children's Hospital (1)  ·  Oslo University Hospital (1)

Countries

United States (9)  ·  China (2)  ·  Canada (1)  ·  Germany (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Mark Reisman, MD (2)  ·  Aditya K Kaza, MD (1)  ·  Adnan T Bhutta, MD (1)  ·  Allan Doctor, MD (1)  ·  Anthony Furlan, MD (1)  ·  Aymen N Naguib, MD (1)  ·  Catherine Krawczeski, MD (1)  ·  Christopher DeSimone, MD (1)  ·  Frederick E Barr, MD (1)  ·  Gunnar Bentsen, MD (1)  ·  Janet Rush, MD (1)  ·  Paul Friedman, MD (1)  ·  Samuel Asirvatham, MD (1)  ·  Sitaram M Emani, MD (1)

Results publications

PMID 21051670, PMID 21926656, PMID 22417252, PMID 25147037, PMID 26908949, PMID 31211145, PMID 38109984, PMID 42526943

NIH funding

R56HL128813 (1)